ArticleDrugs - real world outcomes2025

Real-World Clinical Characteristics, Treatment Patterns, and Clinical Outcomes in US Patients with Stage I-III Resected NSCLC Without Known EGFR Mutations: The RESECT Study.

Jhanelle E Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.